Muscle relaxant use and the associated risk of Sjögren’s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with ankylosing spondylitis: a population-based cohort study
Therapeutic Advances in Drug Safety · 2026-06 · 17
DOI: 10.1177/20420986261460145 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Therapeutic Advances in Drug Safety, online erschienen am 23.06.2026. Verfasst von Weijie Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, No.318, Chaowang Road, Hangzhou, Zhejiang Province…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Joint TCM Science&Technology Project of National Demonstration Zones for Comprehensive TCM Reform, Natural Science Foundation of Hangzhou.
Abstract (Originalsprache)
Background
Muscle relaxants are widely used for the treatment of ankylosing spondylitis (AS) and inevitably have many adverse reactions. Individuals with AS frequently present with ocular symptoms. However, the association of muscle relaxants with the increase of dry eye or Sjogren’s syndrome (SS) in AS patients remains unclear.
Objectives
To investigate the association between muscle relaxant use and the risks of Sjögren’s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with AS.
Design
A population-based retrospective cohort study.
Methods
This population-based retrospective cohort study identified patients suffering from AS between 2007 and 2017 ( N = 26,806,963) in the National Health Insurance Research Database (NHIRD) of Taiwan. The demographic data of two study groups, namely muscle relaxant users and non-users, were collected in the present study. The inverse probability of treatment weighting (IPTW) was used to balance the clinical confounders. Furthermore, we used Kaplan–Meier analyses and Cox proportional hazard regression to analyze the association between cumulative muscle relaxant use and SS or dry eye risk in AS patients.
Results
After exclusion, 68,970 muscle relaxant users and 31,863 non-users were included in our study. The risks of composite outcome (hazard ratios (HR) 1.37 (1.31–1.43), aHR1.18 (1.13–1.24), and IPTW HR 1.17 (1.13–1.22)), Sjogren’s syndrome (HR 1.63 (1.47–1.79), aHR 1.44 (1.30–1.59), and IPTW HR 1.45 (1.32–1.59)), Dry eye disease (including keratoconjunctivitis sicca) (HR 1.32 (1.26–1.39), aHR 1.12 (1.06–1.17), and IPTW HR 1.11 (1.06–1.16)) were all significantly higher among muscle relaxant users ( p < 0.0001). Moreover, higher doses of muscle relaxant use increased higher risks of composite outcome (25< medication possession ratio (MPR), aHR = 1.77 (1.60–1.96)) and dry eye disease (25< MPR, aHR = 1.74 (1.56–1.94)) ( p < 0.0001 for trend). However, there was higher risk of Sjogren’s syndrome among the patients who received 5< MPR ⩽10 (aHR = 1.70 (1.49–1.93)). Muscle relaxant users who received ethers chemically related to antihistamines and oral muscle relaxant users had higher risks of composite outcome, Sjogren’s syndrome, and dry eye disease.
Conclusion
This study demonstrates that cumulative muscle relaxant exposure might increase the risk of dry eye or even SS at a dose-dependent manner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, No.318, Chaowang Road, Hangzhou, Zhejiang Province 310005, China.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Road, South District, Taichung City 40201, Taiwan.
- Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
ORCID-Profile: Shujun Xia
Förderung
- Joint TCM Science&Technology Project of National Demonstration Zones for Comprehensive TCM Reform
- Natural Science Foundation of Hangzhou
Zitieren
APA
Wang, W., Huang, J., Xia, S., Cai, L., & Wei, J. C. (2026). Muscle relaxant use and the associated risk of Sjögren’s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with ankylosing spondylitis: a population-based cohort study. Therapeutic Advances in Drug Safety, 17. https://doi.org/10.1177/20420986261460145
Vancouver
Wang W, Huang J, Xia S, Cai L, Wei JC. Muscle relaxant use and the associated risk of Sjögren’s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with ankylosing spondylitis: a population-based cohort study. Therapeutic Advances in Drug Safety. 2026;17. doi:10.1177/20420986261460145
BibTeX
@article{Wang2026,
author = {Wang, Weijie and Huang, Jingyang and Xia, Shujun and Cai, Lin and Wei, James Cheng-Chung},
title = {Muscle relaxant use and the associated risk of Sjögren’s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with ankylosing spondylitis: a population-based cohort study},
journal = {Therapeutic Advances in Drug Safety},
year = {2026},
volume = {17},
doi = {10.1177/20420986261460145}
}
EUVIMED